234 results on '"Glidden, David V."'
Search Results
2. Establishing adherence–concentration–efficacy thresholds of TDF–FTC pre-exposure prophylaxis for HIV prevention in African women: a protocol for the Women TDF–FTC Benchmark Study
3. Association of body mass index with progression from binge-eating behavior into binge-eating disorder among adolescents in the United States: a prospective analysis of pooled data
4. Mental Well-Being Among Adversity-Exposed Adolescents During the COVID-19 Pandemic
5. Noninferiority Trials
6. Prospective association of screen time with binge‐eating disorder among adolescents in the United States: The mediating role of depression
7. Reply to: Letter Regarding Time to Extubation Among ARDS Subjects With and Without COVID-19 Pneumonia Manuscript
8. The Impact of a Point of Care Urine Tenofovir Assay on Adherence to PrEP Among Women in Kenya
9. Prevalence and determinants of post-acute sequelae of COVID-19 in Liberia
10. Noninferiority Trials
11. HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus Placebo
12. Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis
13. Estimating counterfactual placebo HIV incidence in HIV prevention trials without placebo arms based on markers of HIV exposure
14. Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection
15. Cyberbullying and eating disorder symptoms in US early adolescents
16. Key concepts in clinical epidemiology: collider-conditioning bias
17. Racial discrimination is associated with binge-eating disorder in early adolescents: a cross-sectional analysis
18. Reply to Authors
19. Mental Health and Gender Affirmation of Black and Latine Transgender/Nonbinary Youth Compared to White Peers Prior to Hormone Initiation
20. Viral Determinants of Acute COVID-19 Symptoms in a Nonhospitalized Adult Population in the Pre-Omicron Era
21. Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV
22. Interpretation of active-control randomised trials: the case for a new analytical perspective involving averted events
23. Time to Extubation Among ARDS Subjects With and Without COVID-19 Pneumonia
24. Racial Discrimination is Associated with Binge-Eating Disorder in Early Adolescents: A Cross-Sectional Analysis
25. Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID
26. Spirometry in Mixed Race Civil War Veterans
27. The Association between Malnutrition and Malaria Infection in Children under 5 Years in Burkina Faso: A Longitudinal Study
28. Updating the adherence-response for oral F-TDF for PrEP among cisgender women
29. Comparing Substance Use and School-Based Stressors Among Black and Latinx Transgender Youth and Peers With Shared Minoritized Identities
30. Study design approaches for future active-controlled HIV prevention trials
31. Prevalence and determinants of Kaposi’s sarcoma-associated herpesvirus (KSHV) antibody positivity among adults living with HIV in East Africa
32. Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding
33. Urine Tenofovir Levels Strongly Correlate With Virologic Suppression in Patients With Human Immunodeficiency Virus on Tenofovir Alafenamide-Based Antiretroviral Therapy
34. Agent Orange Exposure and Risk of Idiopathic Pulmonary Fibrosis among U.S. Veterans
35. Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
36. Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis
37. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection
38. Inflammation during early post-acute COVID-19 is associated with reduced exercise capacity and Long COVID symptoms after 1 year
39. A Feasibility Study of a Remotely-Delivered Mindfulness-Based Training for Adolescents During the COVID-19 Pandemic
40. Characterizing HIV-Preventive, Plasma Tenofovir Concentrations—A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis Clinical Trials
41. Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis
42. POST-ACUTE SEQUELAE AND ADAPTIVE IMMUNE RESPONSES IN PEOPLE LIVING WITH HIV RECOVERING FROM SARS-COV-2 INFECTION
43. Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California
44. Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study
45. Plasma markers of neurologic injury and systemic inflammation in individuals with self-reported neurologic post-acute sequelae of SARS-CoV-2 infection (PASC)
46. LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV
47. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
48. SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV
49. Brief Report: No Difference in Urine Tenofovir Levels in Patients Living With HIV on Unboosted Versus Dose-Adjusted Boosted Tenofovir Alafenamide
50. Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.